Pierre Pujol work email
- Valid
- Valid
- Valid
Pierre Pujol personal email
- Valid
Pierre Pujol phone numbers
Global professional with a track record of successfully developing businesses and mobilizing high-quality teams in the pharma/biotech/cleantech industries. High energy and thoughtful executive who delivered strong results across several businesses and geographies, including the US, Europe and China. I have been passionate about life sciences my entire life and have tried to leverage my interest into meaningful societal impacts throughout my career, from contributing to increasing the animal protein supply in China, to bringing to market new and better medicines, and to fighting industrial pollution. Along this journey, my analytical and people skills brought me to the business side of these scientific endeavors. While I quickly climbed the corporate ladder in large organizations, I also enjoyed my involvement in bold and daring startups. I successfully contributed to the corporate strategy and commercialization activities in two Pharma companies (GSK, Sanofi), to the business development and operational management of several biotech companies (Chiron, Maxygen and Eos) and to the emergence of several start-ups, including Oakbio, Airlib and Trilo Therapeutics, two of which I co-founded.Key skills:- Holistic understanding of the drug R&D / product decision-making process and commercialization.- Complement great scientific teams with commercial /financial insights for efficient decision-making.- Engage effectively cross-functionally at all levels of the organization, from bench to Board. - Excellent analytical skills, qualitative and quantitative, ideal for strategy and product/deal valuations.- Selected to join the elite GSK executive development program and trained by BCG consulting for 1 year.- P&L management, change and transformation, and organization efficiency, including streamlining.- Bridge across cultural gaps for efficient communication (lived /worked in France, China, the UK and the USA).Corporate Strategy, Corporate Development, Clinical trials, Product Management, Drug Development, Strategic Planning, Valuation, Project Management, Management Consulting, Business Process Improvement, Forecasting, Modelling, Marketing, Data Analysis, Business Analysis, Finance, Net Present Value, Team Leadership, Executive Management, International Business, Due-diligence, Microsoft Office, PowerPoint, Excel, P&L management, streamlining organization, organizational efficiency, change and transformation.
-
Chief Business OfficerTrilo Therapeutics Jan 2022 - PresentSan Francisco, California, UsA novel discovery platform of fully synthetic macrocyclic peptidomimetics for ADC drug development. • Co-led the technology platform positioning, drug target selection and business model.• Generated interest from potential pharma collaborators and negotiated the first R&D agreement.• Co-led budgeting and milestones setting, developed promotional materials and funding outreach. -
Co-Founder And Advisory Board MemberAirlib Inc Sep 2016 - PresentScottsdale, Arizona, UsIOT solution to produce interactive high-resolution traffic pollution maps to reduce in-cabin exposure.• Developed the value proposition, go-to-market strategy and recruited key Advisory Board members.• Identified and developed business partnerships with Big Data firms and OEM car manufacturers. -
MentorNasdaq Entrepreneurial Center Jul 2020 - Feb 2022San Francisco, California, Us -
Chief Executive OfficerOakbio Inc. (Now Novonutrients Inc.) Sep 2009 - Aug 2016Fighting Climate Change: A novel bioprocess for industrial emissions (CO2) capture and recycling.• Co-authored and managed grants from CA Energy Commission, CCEMC, Canada and the EU (SMEs). • Sourced and managed collaborations with Shell Petroleum, Lafarge SA, Heidelberg AG and PG&E. • Created a Carbon Life Cycle Assessment model for our technology validated by PWC. • Managed 15 employees, sourced and negotiated a strategic partnership with access to $15M in funding.
-
Senior ConsultantStartups 2001 - Aug 2009Principal at PartnerVision Ventures: Hi-Tech incubator which creates, patents and Seed fund. Think tank of the founder of iAtlas and Hotels.com. Reviewed 50+ investment opportunities, wrote the business plan for VoIP TalkPlus, which raised $5.5M Series A.Co-Founder and CBO at Emiliem Inc. / Elara Biosciences: a spin-off from Eos Therapeutics developing a new platform for toxicogenomics. Wrote the business plan and negotiated gene pool access from Finland and diagnostic supply agreements with Affymetrix and Illumina.Acting VP BD at Eos Therapeutics. Developed analysis to evaluate company's strategic options. My resources planning model guided operations' streamlining prior to the acquisition by Abbvie. Engaged discussions with Roche and Affymetrix to out-license molecular diagnostics markers. -
Vp, Corporate Business DevelopmentMaxygen Oct 2000 - Jul 2001Sunnyvale, California, Us• Developed the first strategic plan and portfolio review process. Oversaw all M&A and BD activities. Set up commercialization structure and product-gating process. Prepared all business materials for the Board of Directors, of which I was a Board Observer. Managed a team of 15 in BD and corporate functions.• Acting President of vaccines business unit with 40 employees, $12M P&L. Negotiated deals with IAVI ($3.6MM), DARPA ($12MM) and Aventis (undisclosed). -
Head, Global Portfolio Analysis Group (Group Vp Level)Glaxo Welcome Plc. ( Now Gsk) 1997 - 2000Head and co-Chair, Global Portfolio Analysis Group (Group VP level)• Designed the “Go/No-Go” product review process at the end of Phase II and Phase III Clinical Trials.• Co-Chaired the review of 7 products, representing a future investment of more than $3B. • Moderated cross-functional teams (Clinical Development, Finance, Manufacturing, Regulatory Affairs and US/EU markets), with independent reviews of inputs to identify key value drivers. • Facilitated the resolution of outstanding issues and prepared final recommendation reports for the Executive Committee decisions.Leader of a Management Consulting team in a Global Commercialization Task Force (Sr. Director level)• A company's wide organizational development effort aimed at improving clinical products' selection and market launch success.• Led a team of Management Consultants (BCG) to improve the inclusion of key commercial and financial inputs into R&D decisions, which eventually led to the creation of the Go/No Go product gating (see above).Director of Business & Commercial Analysis, Global Commercial Strategy Group• Directed market research ($3M/year), sales forecasting, commercial evaluations, data analysis, pipeline strategy and competitive intelligence for the $3B Anti-Infectives Therapy Area.• Contributed commercial analytics into 5 disease management teams including the $1.5B Herpes (Zovirax patent expiry and Valtrex launch), the HIV and STDs teams.• Temporarily assigned to China subsidiary to help prepare the commercial launch of the first-ever HBV therapeutic. Saved $200M in Capex plan.• Initiatives: co-led a $600M acquisition proposal, the in-licensing of 2 therapeutic vaccines and initiated alignment of product financial evaluation methodologies across all R&D.• Hand-picked to become part of the Executive Development Program
-
Director, Strategic Planning And Business DevelopmentChiron Corp. May 1994 - Sep 1995Emeryville, California, Us• Led a cross-functional team to develop the vaccines’ unit first-ever strategic plan, developed a consolidated financial model integrating a major acquisition (Biocine-Sclavo), developed the first product pipeline portfolio management process, which was later expanded to the whole company.• Performed valuation studies for patents and products in-licensing and M&A, led due-diligence process and was part of the team making valuations during negotiations of acquisition by Ciba-Geigy (Novartis).
Pierre Pujol Skills
Pierre Pujol Education Details
-
InseadMba - Additionally Admitted To The Harvard Mba Program -
AgroparistechMsc & Engineering + 3 Years Towards Phd Macroeconomics -
Université Paul Sabatier Toulouse IiiBiology
Frequently Asked Questions about Pierre Pujol
What company does Pierre Pujol work for?
Pierre Pujol works for Trilo Therapeutics
What is Pierre Pujol's role at the current company?
Pierre Pujol's current role is Pharma/Biotech executive, consultant.
What is Pierre Pujol's email address?
Pierre Pujol's email address is pi****@****daq.org
What is Pierre Pujol's direct phone number?
Pierre Pujol's direct phone number is +165025*****
What schools did Pierre Pujol attend?
Pierre Pujol attended Insead, Agroparistech, Université Paul Sabatier Toulouse Iii.
What are some of Pierre Pujol's interests?
Pierre Pujol has interest in Growing Orchids, Finding Ways To Reduce My Carbon Impact, Orchids, Nature And Environment, Health, Saving The Planet, Enjoying Outdoor Activities, Velo, Outdoors, Environment.
What skills is Pierre Pujol known for?
Pierre Pujol has skills like Start Ups, Business Development, Venture Capital, Strategy, Business Strategy, Biotechnology, Entrepreneurship, Cross Functional Team Leadership, Business Planning, Life Sciences, Commercialization, Financial Modeling.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial